Influence of budesonide and fluticasone propionate in the anti-osteoporotic potential in human bone marrow-derived mesenchymal stem cells via stimulation of osteogenic differentiation

Osteoporosis is a prevalent bone condition with adverse effects observed in patients undergoing long-term glucocorticoid therapy, resulting in bone demineralization and tissue loss. There has been limited studies on the global response to dexamethasone in terms of comparing its expression profile to...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Terrence Suministrado Sumague, Abdurahman A. Niazy, Rhodanne Nicole A. Lambarte, Ibrahim A. Nafisah, Arief Gusnanto
Format:	Article
Language:	English
Published:	Elsevier 2024-10-01
Subjects:	Bioinformatics approach Glucocorticoid compound Anti-Osteoporosis Osteogenic differentiation Mesenchymal stem cells
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024155065